Novast Pharmaceuticals' Series D Round

Novast Pharmaceuticals raised a round of funding on June 12, 2012. Investors include Lilly Asia Ventures.

Novast is a generic and specialty pharmaceutical company, operated in both China and the United States. Novast is dedicated to uphold the highest quality and drug delivery technology in product devel…

Articles about Novast Pharmaceuticals' Series D Round: